drugset / Trial / NCT02199223
Regorafenib + Panitumumab for Colorectal Cancers
NaSingle-groupOpen-labelTreatment
Summary
Evaluate the safety of regorafenib and panitumumab
Timeline
- Start
- 2014-06
- Primary completion
- 2016-05
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Panitumumab | Monoclonal antibody | — | — |
| Subject | Regorafenib | Small molecule | — | — |